Peterson Amy C. 4
4 · CytomX Therapeutics, Inc. · Filed Oct 26, 2021
Insider Transaction Report
Form 4
Peterson Amy C.
EVP, Chief Development Officer
Transactions
- Award
Performance Stock Units (PSUs)
2021-10-24+40,000→ 40,000 total→ Common Stock (40,000 underlying) - Award
Stock Option (Right to Buy)
2021-10-24+50,000→ 50,000 totalExercise: $5.34Exp: 2031-10-23→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.
- [F2]Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.